COMMUNIQUÉS West-GlobeNewswire

Health Systems and Strategic Partners Unite to Address Widening Healthcare Gaps in Rural and Underserved Communities
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The National Specialty Care Access Coalition (NSCAC), a collaboration of more than 20 major US health systems, today announced its launch to address the growing breakdown in [...]
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
18/02/2026
- Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales milestones along with tiered single-digit royalties on net product sales - - Rasayana to [...]
Tenvie Therapeutics Appoints Don O’Sullivan, Ph.D., MBA, as Chief Business Officer
18/02/2026
Seasoned biotechnology executive with more than 20 years of corporate and business development experience to lead strategic collaborations and business operations BRISBANE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
18/02/2026
IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global biopharmaceutical industry and [...]
Aspargo Labs Appoints Sam Backenroth as Chief Financial Officer
18/02/2026
Adds experienced public-company finance executive to advance Aspargo’s corporate, commercial, and capital markets strategies NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company [...]
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
18/02/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient [...]
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
18/02/2026
SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]
Imprivata Patient Access Now Available in Epic Toolbox for Identity Verification in MyChart
18/02/2026
Integration strengthens patient identification across all points of care, enhancing PHI security, reducing duplicate medical records, and lowering costs tied to denied or fraudulent claims WALTHAM, Mass., Feb. 18, 2026 [...]
Olympia Pharmaceuticals Unveils Circulate, Expanding Its Single-Dose IV Nutritional Therapy Line
18/02/2026
New vascular health formula designed with blood flow and cellular energy in mind through a streamlined, ready-to-use delivery system ORLANDO, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a leader in [...]
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
18/02/2026
OSHA standardizes on Mesa’s DryCal Defender technology for field enforcement as industry faces generational knowledge gap in flow calibration LAKEWOOD, Colo., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. ( [...]
Design Therapeutics to Participate in Upcoming Investor Conferences
18/02/2026
CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
18/02/2026
- Data presented at Annual Winter Meeting 2026 for the Vascular & Endovascular Surgery Society - - After up to 36 months of follow-up, extremity arterial trauma patients had high rates of limb salvage, low rates of [...]
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
18/02/2026
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung Cancer Trial is fully funded by the U.S. Department of Veterans Affairs and is open for enrollment at 11 VA [...]
Notice to Convene the Annual General Meeting of Genmab A/S
18/02/2026
Company Announcement Genmab A/S to hold Annual General Meeting on Thursday March 19, 2026 COPENHAGEN, Denmark; February 18, 2026 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Thursday, March 19, 2026 [...]
Genelux Corporation to Participate in Upcoming Conferences
18/02/2026
WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that the Company will participate in two upcoming [...]
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
18/02/2026
Tumor Shrinkage of 50% and significant CA-125 biomarker reduction observed at 220 mg dose level Patient experienced only Grade 1 adverse events Represents second patient with PR to harbor PPP2R1A mutation, supporting [...]
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
18/02/2026
Patent strengthens protection for novel PTSD drug and advances the Company’s international IP strategy SARASOTA, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a [...]
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
18/02/2026
BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer [...]

Pages